Top

Published in:

Open Access 01-02-2019 | Letter to the Editor

A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia

Authors: Akira Yamamoto, Yusuke Meguri, Akiko Fukuda, Yui Kambara, Tomohiro Urata, Taiga Kuroi, Taro Masunari, Nobuo Sezaki, Toru Kiguchi

Published in: Annals of Hematology | Issue 2/2019

Excerpt

Dear Editor, …

Ducros A (2012) Reversible cerebral vasoconstriction syndrome. The Lancet Neurology 11(10):906–917. https://doi.org/10.1016/s1474-4422(12)70135-7 CrossRefPubMed

Kazato Y, Fujii K, Oba H, Hino M, Ochiai H, Uchikawa H, Kohno Y (2012) Reversible cerebral vasoconstriction syndrome associated with brain parenchymal hemorrhage. Brain Dev 34(8):696–699. https://doi.org/10.1016/j.braindev.2011.11.001 CrossRefPubMed

Ueki H, Sanayama Y, Miyajima A, Tsuchimochi T, Igarashi S, Sunami S (2016) Reversible cerebral vasoconstriction syndrome promptly diagnosed with magnetic resonance imaging including magnetic resonance angiography during immunosuppressive therapy in a 16-year-old girl with refractory cytopenia of childhood. Hematol Rep 8(4):6673. https://doi.org/10.4081/hr.2016.6673 CrossRefPubMedCentralPubMed

Singhal AB (2004) Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 61(3):411–416. https://doi.org/10.1001/archneur.61.3.411 CrossRefPubMed

Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ (2006) Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology 67(12):2164–2169. https://doi.org/10.1212/01.wnl.0000249115.63436.6d CrossRefPubMed

Fukudo M, Yano I, Masuda S, Okuda M, Inui K-i (2005) Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity. J Pharmacol Exp Ther 312(2):816–825. https://doi.org/10.1124/jpet.104.074930 CrossRefPubMed

Song T, Rao Z, Tan Q, Qiu Y, Liu J, Huang Z, Wang X, Lin T (2016) Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review. Medicine 95(14):e3173. https://doi.org/10.1097/MD.0000000000003173 CrossRefPubMedCentralPubMed

Kumai Y, Seguchi O, Sato T, Wada K, Shiozawa M, Yokota C, Kuroda K, Nakajima S, Sato T, Yanase M, Matsumoto Y, Fukushima S, Fujita T, Kobayashi J, Fukushima N (2017) Reversible cerebral vasoconstriction syndrome after heart transplantation: a case report. Transplant Proc 49(10):2415–2418. https://doi.org/10.1016/j.transproceed.2017.10.016 CrossRefPubMed

Chiu V, Weitz IC, Hermel DJ (2017) Tacrolimus is effective immunosuppressive therapy in aplastic anemia. Blood 130(Suppl 1):1183–1183

10.

Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41(11):2505–2511. https://doi.org/10.1161/strokeaha.109.572313 CrossRefPubMed

Title: A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia
Authors: Akira Yamamoto
Yusuke Meguri
Akiko Fukuda
Yui Kambara
Tomohiro Urata
Taiga Kuroi
Taro Masunari
Nobuo Sezaki
Toru Kiguchi
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 2/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-018-3430-6

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia

Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes

Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma

Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma

A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page